ATE504002T1 - Erkennung und vorhersage von frühgeburten - Google Patents

Erkennung und vorhersage von frühgeburten

Info

Publication number
ATE504002T1
ATE504002T1 AT07700392T AT07700392T ATE504002T1 AT E504002 T1 ATE504002 T1 AT E504002T1 AT 07700392 T AT07700392 T AT 07700392T AT 07700392 T AT07700392 T AT 07700392T AT E504002 T1 ATE504002 T1 AT E504002T1
Authority
AT
Austria
Prior art keywords
prediction
detection
premature birth
technology described
predicting
Prior art date
Application number
AT07700392T
Other languages
English (en)
Inventor
Lucilla Poston
Andrew Shennan
Original Assignee
Perkinelmer Las Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perkinelmer Las Inc filed Critical Perkinelmer Las Inc
Application granted granted Critical
Publication of ATE504002T1 publication Critical patent/ATE504002T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Mold Materials And Core Materials (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Holo Graphy (AREA)
AT07700392T 2006-01-17 2007-01-17 Erkennung und vorhersage von frühgeburten ATE504002T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0600916.1A GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia
PCT/GB2007/000123 WO2007083099A1 (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia

Publications (1)

Publication Number Publication Date
ATE504002T1 true ATE504002T1 (de) 2011-04-15

Family

ID=35998177

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07700392T ATE504002T1 (de) 2006-01-17 2007-01-17 Erkennung und vorhersage von frühgeburten

Country Status (10)

Country Link
US (1) US7638287B2 (de)
EP (1) EP1974220B1 (de)
JP (1) JP2009524014A (de)
AT (1) ATE504002T1 (de)
AU (1) AU2007206756B2 (de)
CA (1) CA2602681C (de)
DE (1) DE602007013524D1 (de)
ES (1) ES2364314T3 (de)
GB (1) GB0600916D0 (de)
WO (1) WO2007083099A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA022609B1 (ru) 2007-02-12 2016-02-29 А1М Фарма Аб Применение свободного фетального гемоглобина в качестве маркера преэклампсии
GB0715030D0 (en) * 2007-08-02 2007-09-12 Wilson Carol J Testing process
WO2009094665A1 (en) * 2008-01-25 2009-07-30 Perkinelmer Health Sciences, Inc. Methods for determining the risk of prenatal complications
US20110294227A1 (en) * 2008-11-20 2011-12-01 Perkinelmer Health Sciences, Inc. Method for determining the risk of preeclampsia using pigf-2 and pigf-3 markers
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
HRP20150802T1 (xx) * 2010-03-24 2015-11-06 Preelumina Diagnostics Ab Hbf i a1m kao markeri za rano otkrivanje preeklampsije
AU2012351504C1 (en) * 2011-12-15 2018-04-26 Mycartis N.V. Biomarkers and parameters for preeclampsia
US20150157276A1 (en) * 2012-04-24 2015-06-11 Siemens Healthcare Diagnostics Inc. Pre-eclampsia screening methods
EP2954324B1 (de) * 2013-02-08 2019-07-31 University of Iowa Research Foundation Veerwendung von copeptin zur vorhersage des ausbrechens von präeklampsie
US10119978B2 (en) 2013-03-15 2018-11-06 Wallac Oy System and method for determining risk of diabetes based on biochemical marker analysis
PL3189336T3 (pl) 2014-09-02 2019-07-31 Wallac Oy Sposób określania ryzyka stanu przedrzucawkowego
FR3037657B1 (fr) * 2015-06-22 2017-06-23 Univ Rouen Centre Hospitalier Methode de diagnostic des troubles causes par l'alcoolisation foetale
WO2019099998A1 (en) * 2017-11-17 2019-05-23 University Of Washington Connected system for information-enhanced test results
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor
WO2022173786A1 (en) * 2021-02-10 2022-08-18 Mirvie, Inc. Methods and systems for conducting pregnancy-related clinical trials
FR3157091A1 (fr) * 2023-12-26 2025-06-27 Universite De Montpellier Prédiction du comportement biomécanique de la paroi artérielle à travers l’analyse temporelle du signal oscillométrique au cours de la mesure de pression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998028006A1 (en) 1996-12-23 1998-07-02 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
GB0026823D0 (en) 2000-11-02 2000-12-20 King S College London Diagnosis of pre-eclampsia
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
GB0308967D0 (en) * 2003-04-17 2003-05-28 Univ London Screen for pre-eclampsia
ES2556164T3 (es) * 2003-09-23 2016-01-13 The General Hospital Corporation Cribado de la preeclampsia
CA2485722A1 (en) * 2003-10-22 2005-04-22 Paul Lehmann Soluble transferrin receptor

Also Published As

Publication number Publication date
AU2007206756A1 (en) 2007-07-26
CA2602681C (en) 2017-03-14
CA2602681A1 (en) 2007-07-26
US7638287B2 (en) 2009-12-29
EP1974220A1 (de) 2008-10-01
EP1974220B1 (de) 2011-03-30
ES2364314T3 (es) 2011-08-31
GB0600916D0 (en) 2006-02-22
JP2009524014A (ja) 2009-06-25
DE602007013524D1 (de) 2011-05-12
HK1119244A1 (en) 2009-02-27
ES2364314T8 (es) 2011-09-22
AU2007206756B2 (en) 2011-06-16
WO2007083099A1 (en) 2007-07-26
US20070178530A1 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
ATE504002T1 (de) Erkennung und vorhersage von frühgeburten
WO2009058902A3 (en) Methods and devices for analyte detection
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2012021795A3 (en) Pancreatic cancer biomarkers and uses thereof
MX2020004617A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
WO2008019375A3 (en) Proteomic patterns of cancer prognostic and predictive signatures
NZ602056A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2008021290A3 (en) Organ-specific proteins and methods of their use
DK2885641T3 (da) Fremgangsmådeer til forudsigelse af risiko for udvikling af hypertension
WO2014065889A3 (en) Multiplexed method for diagnosing classical hodgkin lymphoma
NZ609824A (en) Immunochromatography devices, methods and kits
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
BR112013006240A2 (pt) processo para detecção, diferenciação e quantificação de populações de células-t através da tecnologia quantitativa pcr (rt-qpcr) de transcrição reversa, em tempo real
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
WO2012082742A3 (en) Detecting cancer with anti-ccl25 and anti-ccr9 antibodies
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests
MY145455A (en) Diagnostic biomolecule(s)
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
WO2008124091A3 (en) Compositions and methods of detection
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
MX2009008525A (es) La determinacion cuantitativa de risedronato en orina mediante spe-lc-ms-ms.
EP1924710A4 (de) Verfahren zur diagnose eines ovarialkarzinoms und kits dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties